304 related articles for article (PubMed ID: 12366839)
41. The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium.
Barlow PG; Beaumont PE; Cosseau C; Mackellar A; Wilkinson TS; Hancock RE; Haslett C; Govan JR; Simpson AJ; Davidson DJ
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):692-702. PubMed ID: 20097832
[TBL] [Abstract][Full Text] [Related]
42. The antibacterial activity of LL-37 against Treponema denticola is dentilisin protease independent and facilitated by the major outer sheath protein virulence factor.
Rosen G; Sela MN; Bachrach G
Infect Immun; 2012 Mar; 80(3):1107-14. PubMed ID: 22184422
[TBL] [Abstract][Full Text] [Related]
43. Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.
Rapala-Kozik M; Bochenska O; Zawrotniak M; Wolak N; Trebacz G; Gogol M; Ostrowska D; Aoki W; Ueda M; Kozik A
Infect Immun; 2015 Jun; 83(6):2518-30. PubMed ID: 25847962
[TBL] [Abstract][Full Text] [Related]
44. A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides.
Hollands A; Gonzalez D; Leire E; Donald C; Gallo RL; Sanderson-Smith M; Dorrestein PC; Nizet V
J Biol Chem; 2012 Nov; 287(49):40891-7. PubMed ID: 23038245
[TBL] [Abstract][Full Text] [Related]
45. Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth.
Schmidtchen A; Holst E; Tapper H; Björck L
Microb Pathog; 2003 Jan; 34(1):47-55. PubMed ID: 12620384
[TBL] [Abstract][Full Text] [Related]
46. Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.
Catanese J; Kress LF
Biochim Biophys Acta; 1984 Aug; 789(1):37-43. PubMed ID: 6432051
[TBL] [Abstract][Full Text] [Related]
47. Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.
Sol A; Skvirsky Y; Nashef R; Zelentsova K; Burstyn-Cohen T; Blotnick E; Muhlrad A; Bachrach G
J Biol Chem; 2014 Aug; 289(33):22926-22941. PubMed ID: 24947511
[TBL] [Abstract][Full Text] [Related]
48. Tissue-specific Regulation of Innate Immune Responses by Human Cathelicidin LL-37.
Chieosilapatham P; Ikeda S; Ogawa H; Niyonsaba F
Curr Pharm Des; 2018; 24(10):1079-1091. PubMed ID: 29589544
[TBL] [Abstract][Full Text] [Related]
49. [The effect of subinhibitory concentrations of norfloxacin, erythromycin and roxithromycin on Pseudomonas aeruginosa virulence factors].
Hostacká A
Epidemiol Mikrobiol Imunol; 1995 Sep; 44(3):115-7. PubMed ID: 7489133
[TBL] [Abstract][Full Text] [Related]
50. Analysis of protease activity in human otitis media.
Avidano MA; Cotter CS; Stringer SP; Schultz GS
Otolaryngol Head Neck Surg; 1998 Oct; 119(4):346-51. PubMed ID: 9781988
[TBL] [Abstract][Full Text] [Related]
51. OmpT outer membrane proteases of enterohemorrhagic and enteropathogenic Escherichia coli contribute differently to the degradation of human LL-37.
Thomassin JL; Brannon JR; Gibbs BF; Gruenheid S; Le Moual H
Infect Immun; 2012 Feb; 80(2):483-92. PubMed ID: 22144482
[TBL] [Abstract][Full Text] [Related]
52. Inactivation of the antimicrobial peptide LL-37 by pathogenic Leptospira.
Oliveira PN; Courrol DS; Chura-Chambi RM; Morganti L; Souza GO; Franzolin MR; Wunder EA; Heinemann MB; Barbosa AS
Microb Pathog; 2021 Jan; 150():104704. PubMed ID: 33347965
[TBL] [Abstract][Full Text] [Related]
53. LL-37 Triggers Formation of Streptococcus pyogenes Extracellular Vesicle-Like Structures with Immune Stimulatory Properties.
Uhlmann J; Rohde M; Siemens N; Kreikemeyer B; Bergman P; Johansson L; Norrby-Teglund A
J Innate Immun; 2016; 8(3):243-57. PubMed ID: 26641861
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37.
Strömstedt AA; Pasupuleti M; Schmidtchen A; Malmsten M
Antimicrob Agents Chemother; 2009 Feb; 53(2):593-602. PubMed ID: 19029324
[TBL] [Abstract][Full Text] [Related]
55. Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue.
Hosokawa I; Hosokawa Y; Komatsuzawa H; Goncalves RB; Karimbux N; Napimoga MH; Seki M; Ouhara K; Sugai M; Taubman MA; Kawai T
Clin Exp Immunol; 2006 Nov; 146(2):218-25. PubMed ID: 17034573
[TBL] [Abstract][Full Text] [Related]
56. The human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to activate expression of virulence factors.
Velarde JJ; Ashbaugh M; Wessels MR
J Biol Chem; 2014 Dec; 289(52):36315-24. PubMed ID: 25378408
[TBL] [Abstract][Full Text] [Related]
57. Activity of antimicrobial peptides in the presence of polysaccharides produced by pulmonary pathogens.
Benincasa M; Mattiuzzo M; Herasimenka Y; Cescutti P; Rizzo R; Gennaro R
J Pept Sci; 2009 Sep; 15(9):595-600. PubMed ID: 19466693
[TBL] [Abstract][Full Text] [Related]
58. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.
Jacobsen F; Mittler D; Hirsch T; Gerhards A; Lehnhardt M; Voss B; Steinau HU; Steinstraesser L
Gene Ther; 2005 Oct; 12(20):1494-502. PubMed ID: 15973442
[TBL] [Abstract][Full Text] [Related]
59. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.
Turner J; Cho Y; Dinh NN; Waring AJ; Lehrer RI
Antimicrob Agents Chemother; 1998 Sep; 42(9):2206-14. PubMed ID: 9736536
[TBL] [Abstract][Full Text] [Related]
60. Role of alkaline protease and elastase in the adherence of Pseudomonas aeruginosa to WEHI cells.
Trancassini M; Magni A; Ghezzi MC; Nazzari C; Brenciaglia MI; Filadoro F
Microbiologica; 1989 Jul; 12(3):257-61. PubMed ID: 2506409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
